Safe Orthopaedics announces CE mark for Sycamore
May 24, 2021 02:34 ET | Source: Safe Orthopaedics Safe Orthopaedics Éragny, FRANCE
Very dynamic market segment
Worldwide commercialization expected in 2022
Éragny-sur-Oise, France, On May 24, 2021 à 8:35 CET – Safe Orthopaedics (FR0013467123 – ALSAF), a holding of the Safe Group (composed of Safe Orthopaedics, a company specializing in the design, manufacturing and marketing of single-use technologies for spinal surgeries, and Safe Medical (Ex-LCI medical), integrated subcontractor for orthopedic medical devices, today announces the CE mark for Sycamore, a new treatment for the management of patients with one or more osteoporotic fractures.
Osteoporotic fracture is a global clinical issue. Driven by the aging population and the dynamic lifestyle of those 50 years and older, the number of vertebral fractures has increased significantly over the past two decades.